Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Similars in SciELO
Share
Arquivos de Medicina
On-line version ISSN 2183-2447
Abstract
FERRAO, Cláudia et al. Our golden rule in Behçet's disease: treating the clinical manifestation. Arq Med [online]. 2015, vol.29, n.3, pp.75-79. ISSN 2183-2447.
Behçet's Disease (BD) is a systemic vasculitis, which can be defined as the frontier between the autoimmune and the auto inflammatory disease. Its etiopathogenesis is still not fully identified, although it is known about the contribution of genetic (MHC Class I association) and environmental factors (higher incidence in specific regions of the globe). There are cells implicated in the pathologic process (neutrophils, macrophages, T regulatory lymphocytes') and other components (tumour necrosis factor/ TNF, interleukins) of the immune system. The clinical manifestations of BD are very heterogeneous, both in severity and in the affected organs: Mucocutaneous Behçet, Ocular Behçet, Vasculobehçet, Neurobehçet, Intestinal Behçet, Cardiac Behçet. Independently of the immune-inflamatory mechanisms in each of the clinical manifestations, the therapeutic must be adapted to each one of them. Our cohort of BD, collected throughout 20 years, is representative of all the clinical spectrum of BD, and we consider it useful to revisit the therapeutic indications, comparing the data from the literature with our clinical experience.
Keywords : behçet; treatment; clinical manifestation.